Literature DB >> 26952647

An FDA oncology view of juvenile animal studies in support of initial pediatric trials for anticancer drugs.

John K Leighton1, Haleh Saber2, Gregory Reaman2, Richard Pazdur2.   

Abstract

Keywords:  First in pediatric trials; Juvenile animal studies

Mesh：

Substances：

Year:  2016        PMID： 26952647     DOI： 10.1016/j.yrtph.2016.03.001

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN： 0273-2300            Impact factor:   3.271


× No keyword cloud information.
  3 in total

Review 1.  Clinical trial enrollment of adolescents and young adults with sarcoma.

Authors:  Lara E Davis; Katherine A Janeway; Aaron R Weiss; Yen-Lin E Chen; Thomas J Scharschmidt; Mark Krailo; Julia L Glade Bender; Lisa M Kopp; Shreyaskumar R Patel; Gary K Schwartz; L Elise Horvath; Douglas S Hawkins; Meredith K Chuk; Denise K Reinke; Richard G Gorlick; R Lor Randall
Journal:  Cancer       Date:  2017-05-11       Impact factor: 6.860

2.  Enrolling Adolescents in Disease/Target-Appropriate Adult Oncology Clinical Trials of Investigational Agents.

Authors:  Meredith K Chuk; Yeruk Mulugeta; Michelle Roth-Cline; Nitin Mehrotra; Gregory H Reaman
Journal:  Clin Cancer Res       Date:  2016-10-25       Impact factor: 12.531

Review 3.  Navigating the Regulatory Landscape to Develop Pediatric Oncology Drugs: Expert Opinion Recommendations.

Authors:  Elly Barry; Darrin Beaupre; Eileen Blasi; Jaimie A Walsh; Scott L Weinrich; Daniel R Arenson; Ira A Jacobs
Journal:  Paediatr Drugs       Date:  2021-06-26       Impact factor: 3.022
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.